Company overview
Basic information
Company name
Bespoke solutions, MB
Company code
306027719
VAT code
LT100015438613
Registered address
Kaunas, Chemijos g. 27C-62, LT-51332
Registration date
2022-03-01
Company age: 4 y. 7 mo.
Contact information
Edit data
Phone
Presented as an image – cannot be copied
Email
Presented as an image – cannot be copied
Website
None
Company manager
For registered members only
Log in
Indicators
Risk factors
Activity
Legal form
Small partnership
NACE activity
Installation of electrical wiring and fittings in buildings
Ownership form
Private without foreign capital
MB "Bespoke solutions"
Company code: 306027719
Address: Kaunas, Chemijos g. 27C-62, LT-51332
VAT code: LT100015438613
Description
This description was generated by artificial intelligence.
Bespoke solutions, MB (company code 306027719) is an operational private small partnership registered on 1 March 2022. It belongs to the sector of national private non-financial companies and is classified as private ownership, with Lithuanian natural and legal persons holding more than 50% of the authorised capital and no foreign investor capital. The company is governed by a CEO only and is identified as a micro company. Its activity is classified under EVRK code F.43.21.10, Installation of electrical wiring and fittings in buildings and constructions. The company is based in Kaunas, Kauno m. sav., Kauno apskr., at Chemijos g. 27C-62, LT-51332. Financially, the company generated revenue of EUR 30.2K in 2025, down 34.6% year on year and 32.1% over two years. Even so, profitability improved: net profit reached EUR 16.0K in 2025, with a profit margin of 53.0%. Equity increased to EUR 52.3K, liabilities declined to EUR 1.0K, and total assets stood at EUR 53.3K. The latest financial structure indicates a very strong equity position and high asset coverage.
Download a detailed company report
Make confident decisions with all the information about Bespoke solutions, MB. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.